Atenolol Tablet
FDA Label NDC 65841-022

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Atenolol (NDC 65841-022). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-022-01 in bottles of 100 tablets

Atenolol Tablets USP, 25 mg

R_x only

100 Tablets

Atenolol Tablets, 25 mg (Bcbd44a4 Cd4d 4692 Bab0 6b9267f0172d 02)

NDC 65841-023-01 in bottles of 100 tablets

Atenolol Tablets USP, 50 mg

R_x only

100 Tablets

Atenolol Tablets, 50 mg (Bcbd44a4 Cd4d 4692 Bab0 6b9267f0172d 03)

NDC 65841-024-01 in bottles of 100 tablets

Atenolol Tablets USP, 100 mg

R_x only

100 Tablets

Atenolol Tablets, 100 mg (Bcbd44a4 Cd4d 4692 Bab0 6b9267f0172d 04)

* Please review the disclaimer below.